Insights

Small biotech Allegro Ophthalmics is a late-stage ophthalmic biopharma with a small team (2-10 employees) and moderate revenue, indicating a nimble organization that can rapidly partner on near-term BD opportunities and licensing deals.

Strategic collaboration The company emphasizes integrin inhibition therapy for retinal diseases and has a Phase 2 success poised to move to Phase 3, presenting a clear opportunity for strategic partnerships, co-development, or out-licensing deals with larger pharma players seeking late-stage assets.

Funding readiness With a total funding of about 43 million and prior Series-like financing, Allegro may be open to additional funding rounds or milestone-based collaborations that provide development funds in exchange for downstream royalties or commercialization rights.

Clinical leadership Key leadership changes in finance and governance plus a history of appointing experienced executives suggest a company receptive to structured BD interactions, due diligence collaboration, and strategic advisory roles to accelerate late-stage development.

Market positioning Focused on retinal diseases such as diabetic macular edema and dry AMD with a broad-spectrum integrin inhibitor, Allegro targets a large, high-need market; potential sales opportunities exist with ophthalmology networks, specialty retailers, and payer collaborations seeking disease-modifying treatments.

Similar companies to Allegro Ophthalmics, LLC

Allegro Ophthalmics, LLC Tech Stack

Allegro Ophthalmics, LLC uses 8 technology products and services including WordPress, Shopify, Microsoft 365, and more. Explore Allegro Ophthalmics, LLC's tech stack below.

  • Content Management System
  • E-commerce
  • Font Awesome
    Font Scripts
  • Reveal.js
    Javascript Frameworks
  • PHP
    Programming Languages
  • Google Tag Manager
    Tag Management
  • Sitelinks Search Box
    Web Tools And Plugins

Media & News

Allegro Ophthalmics, LLC's Email Address Formats

Allegro Ophthalmics, LLC uses at least 1 email format:
Allegro Ophthalmics, LLC Email FormatsExamplePercentage
FLast@allegroeye.comJDoe@allegroeye.com
100%

Frequently Asked Questions

What is Allegro Ophthalmics, LLC's phone number?

Minus sign iconPlus sign icon
You can contact Allegro Ophthalmics, LLC's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Allegro Ophthalmics, LLC's official website and social media links?

Minus sign iconPlus sign icon
Allegro Ophthalmics, LLC's official website is allegroeye.com and has social profiles on LinkedIn.

How much revenue does Allegro Ophthalmics, LLC generate?

Minus sign iconPlus sign icon
As of October 2026, Allegro Ophthalmics, LLC's annual revenue is estimated to be $1M - $10M.

What is Allegro Ophthalmics, LLC's SIC code and NAICS code?

Minus sign iconPlus sign icon
Allegro Ophthalmics, LLC's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Allegro Ophthalmics, LLC have currently?

Minus sign iconPlus sign icon
As of October 2026, Allegro Ophthalmics, LLC has approximately 3 employees across 1 continents, including North America. Key team members include Research Scientist: Z. S. Explore Allegro Ophthalmics, LLC's employee directory with LeadIQ.

What industry does Allegro Ophthalmics, LLC belong to?

Minus sign iconPlus sign icon
Allegro Ophthalmics, LLC operates in the Pharmaceutical Manufacturing industry.

What technology does Allegro Ophthalmics, LLC use?

Minus sign iconPlus sign icon
Allegro Ophthalmics, LLC's tech stack includes WordPress, Shopify, Microsoft 365, Font Awesome, Reveal.js, PHP, Google Tag Manager and Sitelinks Search Box.

What is Allegro Ophthalmics, LLC's email format?

Minus sign iconPlus sign icon
Allegro Ophthalmics, LLC's email format typically follows the pattern of FLast@allegroeye.com. Find more Allegro Ophthalmics, LLC email formats with LeadIQ.

How much funding has Allegro Ophthalmics, LLC raised to date?

Minus sign iconPlus sign icon
As of October 2026, Allegro Ophthalmics, LLC has raised $43M in funding. The last funding round occurred on Jul 24, 2017.

When was Allegro Ophthalmics, LLC founded?

Minus sign iconPlus sign icon
Allegro Ophthalmics, LLC was founded in 2011.
Allegro Ophthalmics, LLC logo

Allegro Ophthalmics, LLC

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

Allegro Ophthalmics, LLC is a small biopharmaceutical company focused on developing therapies for retinal diseases. Its lead investigational drug, risuteganib (Luminate), is described as a broad-spectrum integrin inhibitor that targets oxidative stress at its source and potentially influences multiple pathways implicated in conditions such as diabetic macular edema and dry AMD. The firm positions itself as a late-stage player in the ophthalmic field, pursuing approaches intended to redefine treatment for retinal disorders.

Headquartered in San Juan Capistrano, California, Allegro operates within the pharmaceutical sector with an emphasis on ophthalmic therapies. Recent activity includes participation in the 2025 Animal Health Europe Conference, where the company was recognized with the Companion Animals Prize, indicating broader engagement and visibility.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2011
Employees
2-10

Section iconFunding & Financials

  • $43M

    Allegro Ophthalmics, LLC has raised a total of $43M of funding over 4 rounds. Their latest funding round was raised on Jul 24, 2017 as a Private Equity.

  • $1M - $10M

    Allegro Ophthalmics, LLC's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.